Access to Medicare increases lung cancer screening rates
If lung cancer is caught early enough, it’s treatable with a high chance of long survival. But many people at high risk because of their smoking history aren’t screened until they turn 65 and are eligible for Medicare coverage.
Lung cancer screening guidelines may perpetuate disparities in health care
Recent changes to national guidelines made more former and current smokers eligible for lung cancer screening, but a new study by a University of Wisconsin School of Medicine and Public Health radiologist shows they did little to close the gap between people of color and white people when it comes to who is eligible to get the scan.
UW researchers focus on boosting colorectal cancer screening rates in rural areas
Researchers at UW Carbone Cancer Center are working to understand why some primary care clinics in rural locations have successfully attained high rates of colorectal cancer screenings, insight they hope will help raise the rates of colorectal cancer screenings across all rural clinics.
Patient with rare cancer uses telehealth to access clinical trial
Today is National Clinical Trials Day, and UW Health wants to celebrate the researchers, nurses, physicians and experts in the lab who make clinical trials available and impactful for our patients and community. UW Health officials also say virtual consultations have been vital to expanding access to clinical trials for Wisconsin residents, especially during the pandemic.
Nataliya Uboha named faculty leader of Cancer Therapy Discovery and Development (CTD2) at UW Carbone Cancer Center
Nataliya Uboha, MD, PhD, has been selected to lead the Cancer Therapy Discovery and Development (CTD2) program at the University of Wisconsin Carbone Cancer Center.
Study finds analyzing DNA in urine could help detect cancer
A study published this week in Science Translational Medicine describes how urinalysis could potentially be used to detect some forms of cancer.
Jamey Weichert, Zachary Morris leading a team to develop new way to help immune system fight back against cancer
Scientists at the University of Wisconsin School of Medicine and Public Health are breaking new ground to make cancer cells more susceptible to attack by the body’s own immune system.
First-in-humans clinical trial to treat children with relapsed neuroblastoma opens at American Family Children’s Hospital
A first-in-humans clinical trial for children with relapsed or refractory neuroblastoma has opened at American Family Children’s Hospital (AFCH) and is being conducted by researchers at University of Wisconsin School of Medicine and Public Health. Neuroblastoma is one of the most common solid tumors in children. Patients who are classified as “high-risk” (about 40 percent of those diagnosed) have less than a 50 percent survival rate.
UW Carbone Cancer Center receives FDA clearance to test new regenerative medicine therapy for radiotherapy-induced dry mouth
The University of Wisconsin Carbone Cancer Center has the go-ahead to start clinical trials on a first-in-human cell therapy to treat a common side effect of radiation therapy.
Stem cells could help cancer patients fight dangerous infections
Scientists at the University of Wisconsin–Madison have developed a more efficient way to grow the white blood cells, which serve as front-line defenders against bacterial infections but are often depleted as a potentially deadly side effect of cancer treatment.
Access to Medicare increases cancer detection, reduces cancer mortality rate
Access to Medicare significantly impacts detection of certain cancers and life expectancy following cancer diagnosis, according to a new study from the UW School of Medicine and Public Health that was recently published online in the Journal of Policy Analysis and Management.
UW–Madison inventors aim to replace old-style breast-surgery marker
Three University of Wisconsin–Madison innovators have invented a better way for surgeons to locate tumors during lumpectomies for breast cancer.